Recent studies have indicated that the mammalian target of rapamycin inhibitor rapamycin promotes erythroid differentiation in pluripotent stem cells and significantly improves the anemic phenotype in patients with Mitochondrial Leukoencephalopathy, Lactic Acidosis, and Stroke-like episodes (24). The gene discussed is MTOR; the disease is Stroke.